BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 22914857)

  • 1. Nitric oxide- and heme-independent activation of soluble guanylate cyclase attenuates peroxynitrite-induced endothelial dysfunction in rat aorta.
    Korkmaz S; Loganathan S; Mikles B; Radovits T; Barnucz E; Hirschberg K; Li S; Hegedüs P; Páli S; Weymann A; Karck M; Szabó G
    J Cardiovasc Pharmacol Ther; 2013 Jan; 18(1):70-7. PubMed ID: 22914857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent effects of a selective phosphodiesterase-5-inhibitor on endothelial dysfunction induced by peroxynitrite in rat aorta.
    Korkmaz S; Radovits T; Barnucz E; Neugebauer P; Arif R; Hirschberg K; Loganathan S; Seidel B; Karck M; Szabó G
    Eur J Pharmacol; 2009 Aug; 615(1-3):155-62. PubMed ID: 19482016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury.
    Korkmaz S; Radovits T; Barnucz E; Hirschberg K; Neugebauer P; Loganathan S; Veres G; Páli S; Seidel B; Zöllner S; Karck M; Szabó G
    Circulation; 2009 Aug; 120(8):677-86. PubMed ID: 19667237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-conditioning with the soluble guanylate cyclase activator Cinaciguat reduces ischaemia-reperfusion injury after cardiopulmonary bypass.
    Radovits T; Korkmaz S; Miesel-Gröschel C; Seidel B; Stasch JP; Merkely B; Karck M; Szabó G
    Eur J Cardiothorac Surg; 2011 Feb; 39(2):248-55. PubMed ID: 20591683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
    Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB
    Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of soluble guanylate cyclase activation on heart transplantation in a rat model.
    Loganathan S; Korkmaz-Icöz S; Radovits T; Li S; Mikles B; Barnucz E; Hirschberg K; Karck M; Szabó G
    J Heart Lung Transplant; 2015 Oct; 34(10):1346-53. PubMed ID: 26210750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-DOPA inhibits nitric oxide-dependent vasorelaxation via production of reactive oxygen species in rat aorta.
    Yinhua ; Harada N; Mawatari K; Yasui S; Segawa H; Takahashi A; Oshita S; Nakaya Y
    J Med Invest; 2009 Aug; 56(3-4):120-9. PubMed ID: 19763024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels.
    Stasch JP; Schmidt PM; Nedvetsky PI; Nedvetskaya TY; H S AK; Meurer S; Deile M; Taye A; Knorr A; Lapp H; Müller H; Turgay Y; Rothkegel C; Tersteegen A; Kemp-Harper B; Müller-Esterl W; Schmidt HH
    J Clin Invest; 2006 Sep; 116(9):2552-61. PubMed ID: 16955146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
    Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
    Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible Activation and Stabilization of Soluble Guanylate Cyclase by the Protoporphyrin IX Mimetic Cinaciguat.
    Kollau A; Opelt M; Wölkart G; Gorren ACF; Russwurm M; Koesling D; Mayer B; Schrammel A
    Mol Pharmacol; 2018 Feb; 93(2):73-78. PubMed ID: 29138269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of peroxynitrite on relaxation through the NO/sGC/cGMP pathway in isolated rat iliac arteries.
    Tawa M; Shimosato T; Iwasaki H; Imamura T; Okamura T
    J Vasc Res; 2014; 51(6):439-46. PubMed ID: 25634663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension.
    Chester M; Seedorf G; Tourneux P; Gien J; Tseng N; Grover T; Wright J; Stasch JP; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L755-64. PubMed ID: 21856817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of soluble guanylate cyclase in renal hemodynamics and autoregulation in the rat.
    Dautzenberg M; Kahnert A; Stasch JP; Just A
    Am J Physiol Renal Physiol; 2014 Nov; 307(9):F1003-12. PubMed ID: 25209860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Activation of Heme Free Guanylate Cyclase Leads to Renal Protection in Dahl Salt-Sensitive Rats.
    Hoffmann LS; Kretschmer A; Lawrenz B; Hocher B; Stasch JP
    PLoS One; 2015; 10(12):e0145048. PubMed ID: 26717150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus.
    Chester M; Tourneux P; Seedorf G; Grover TR; Gien J; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2009 Aug; 297(2):L318-25. PubMed ID: 19465519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of vasorelaxation induced by ethanol extract of Sophora flavescens in rat aorta.
    Jin SN; Wen JF; Li X; Kang DG; Lee HS; Cho KW
    J Ethnopharmacol; 2011 Sep; 137(1):547-52. PubMed ID: 21704693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress impairs vasorelaxation induced by the soluble guanylyl cyclase activator BAY 41-2272 in spontaneously hypertensive rats.
    Priviero FB; Zemse SM; Teixeira CE; Webb RC
    Am J Hypertens; 2009 May; 22(5):493-9. PubMed ID: 19247264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deconstructing endothelial dysfunction: soluble guanylyl cyclase oxidation and the NO resistance syndrome.
    Gladwin MT
    J Clin Invest; 2006 Sep; 116(9):2330-2. PubMed ID: 16955136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular dysfunction induced by hypochlorite is improved by the selective phosphodiesterase-5-inhibitor vardenafil.
    Radovits T; Arif R; Bömicke T; Korkmaz S; Barnucz E; Karck M; Merkely B; Szabó G
    Eur J Pharmacol; 2013 Jun; 710(1-3):110-9. PubMed ID: 23623933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lignan (-)-cubebin inhibits vascular contraction and induces relaxation via nitric oxide activation in isolated rat aorta.
    Carvalho MT; Rezende KC; Evora PR; Bastos JK; Cunha WR; Andrade E Silva ML; Celotto AC
    Phytother Res; 2013 Dec; 27(12):1784-9. PubMed ID: 23401173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.